169 related articles for article (PubMed ID: 27776386)
21. Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects.
Choi KH; Higgs BW; Weis S; Song J; Llenos IC; Dulay JR; Yolken RH; Webster MJ
BMC Psychiatry; 2009 Sep; 9():57. PubMed ID: 19758435
[TBL] [Abstract][Full Text] [Related]
22. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
[TBL] [Abstract][Full Text] [Related]
23. A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics.
Gilca M; Piriu G; Gaman L; Delia C; Iosif L; Atanasiu V; Stoian I
Psychopharmacology (Berl); 2014 Dec; 231(24):4703-10. PubMed ID: 24871701
[TBL] [Abstract][Full Text] [Related]
24. Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55 M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report.
Bahrehmand F; Vaisi-Raygani A; Rahimi Z; Ahmadi R; Kiani A; Tavilani H; Vaisi-Raygani H; Pourmotabbed T
Lupus; 2014 Mar; 23(3):263-72. PubMed ID: 24399815
[TBL] [Abstract][Full Text] [Related]
25. Serum paraoxonase and arylesterase activities in patients with chronic otitis media.
Turan M; Ucler R; Aslan M; Kalkan F; Taskın A; Garca MF; Cankaya H
Redox Rep; 2015; 20(6):241-5. PubMed ID: 25968808
[TBL] [Abstract][Full Text] [Related]
26. [Schizophrenia, diabetes mellitus and antipsychotics].
Gury C
Encephale; 2004; 30(4):382-91. PubMed ID: 15538314
[TBL] [Abstract][Full Text] [Related]
27. Paraoxonase 1 phenotype and paraoxonase activity in asthmatic patients.
Sarioglu N; Hismiogullari AA; Erel F; Demir D; Gencer N
Iran J Allergy Asthma Immunol; 2015 Feb; 14(1):60-6. PubMed ID: 25530140
[TBL] [Abstract][Full Text] [Related]
28. Serum lipid profile paraoxonase and arylesterase activities in psoriasis.
Toker A; Kadi M; Yildirim AK; Aksoy H; Akçay F
Cell Biochem Funct; 2009 Apr; 27(3):176-80. PubMed ID: 19330810
[TBL] [Abstract][Full Text] [Related]
29. Activity of paraoxonase 1 and lipid profile in healthy children.
Sumegová K; Nagyová Z; Waczulíková I; Zitnanová I; Duracková Z
Physiol Res; 2007; 56(3):351-357. PubMed ID: 16792468
[TBL] [Abstract][Full Text] [Related]
30. Oxidant and antioxidant of arylesterase and paraoxonase as biomarkers in patients with hepatitis C virus.
Ali EM; Shehata HH; Ali-Labib R; Esmail Zahra LM
Clin Biochem; 2009 Sep; 42(13-14):1394-400. PubMed ID: 19538950
[TBL] [Abstract][Full Text] [Related]
31. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain.
Pillai A; Parikh V; Terry AV; Mahadik SP
J Psychiatr Res; 2007 Aug; 41(5):372-86. PubMed ID: 16564057
[TBL] [Abstract][Full Text] [Related]
32. Paraoxonase-1 (PON1) activity as a risk factor for atherosclerosis in chronic renal failure patients.
Saeed SA; Elsharkawy M; Elsaeed K; Fooda O
Hemodial Int; 2008 Oct; 12(4):471-9. PubMed ID: 19090870
[TBL] [Abstract][Full Text] [Related]
33. Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia.
Dakhale GN; Khanzode SD; Khanzode SS; Saoji A
Psychopharmacology (Berl); 2005 Nov; 182(4):494-8. PubMed ID: 16133138
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis.
Olama SM; Elarman MM
Rheumatol Int; 2013 Jun; 33(6):1487-94. PubMed ID: 23239038
[TBL] [Abstract][Full Text] [Related]
35. Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.
Qi LY; Xiu MH; Chen DC; Wang F; Kosten TA; Kosten TR; Zhang XY
Neurosci Lett; 2009 Sep; 462(2):113-7. PubMed ID: 19539717
[TBL] [Abstract][Full Text] [Related]
36. Assessing the relationship between antipsychotic drug use and prolidase enzyme activity and oxidative stress in schizophrenia patients: a case-control study.
Yazla E; Cetin I; Kayadibi H
Int Clin Psychopharmacol; 2023 Nov; 38(6):394-401. PubMed ID: 37490605
[TBL] [Abstract][Full Text] [Related]
37. Decreased serum paraoxonase 1 activity and increased serum homocysteine and malondialdehyde levels in age-related macular degeneration.
Ates O; Azizi S; Alp HH; Kiziltunc A; Beydemir S; Cinici E; Kocer I; Baykal O
Tohoku J Exp Med; 2009 Jan; 217(1):17-22. PubMed ID: 19155603
[TBL] [Abstract][Full Text] [Related]
38. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
Aslan M; Kosecik M; Horoz M; Selek S; Celik H; Erel O
Atherosclerosis; 2007 Apr; 191(2):397-402. PubMed ID: 16684543
[TBL] [Abstract][Full Text] [Related]
39. Paraoxonase activity in healthy, diabetic, and hemodialysis patients.
Gbandjaba NY; Ghalim N; Hassar M; Berrougui H; Labrazi H; Taki H; Saile R; Khalil A
Clin Biochem; 2012 Apr; 45(6):470-4. PubMed ID: 22285382
[TBL] [Abstract][Full Text] [Related]
40. Alteration of HDL functionality and PON1 activities in acute coronary syndrome patients.
Bounafaa A; Berrougui H; Ikhlef S; Essamadi A; Nasser B; Bennis A; Yamoul N; Ghalim N; Khalil A
Clin Biochem; 2014 Dec; 47(18):318-25. PubMed ID: 25218815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
